Orateur
Prof.
Benjamin Guillet
(CERIMED Marseille)
Description
The use of ionizing radiation-emitting isotopes in human medicine has been widespread throughout the world for over 70 years. The 2000th saw with the rise of PET imaging a significant increase in the impact of molecular imaging in the management of patients, and more recently the advent of vectorized internal radiotherapy (VIR) of neuroendocrine tumors has represented a new boom in our practices. In this new context, numerous preclinical developments have been initiated worldwide, notably within our C2VN/CERIMED research center, mainly dedicated to 1) the identification of new molecular targets, 2) the development of new vectorization tools, 3) the optimization of VIR therapies already available in clinics.
Author
Prof.
Benjamin Guillet
(CERIMED Marseille)
